Engineering Peptide Inhibitors of the HFE-Transferrin Receptor 1 Complex

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Hereditary hemochromatosis (HH-type I) is linked to mutations in the HFE protein, a key regulator of iron metabolism.
• HFE interacts with transferrin receptor 1 (TFR1), which mediates cellular iron uptake via holo-transferrin binding.
• A proposed mechanism suggests HFE/TFR1 interaction acts as a sensor for circulating iron levels through competitive binding.

Purpose of the Study:

• To investigate the hypothesized competition mechanism between HFE and holo-transferrin for TFR1 binding.
• To develop and test peptide-based inhibitors of the HFE/TFR1 protein-protein interaction.
• To assess the potential of these inhibitors as tools for studying HFE's role in hepcidin regulation.

Main Methods:

• Generation of peptides based on the helical binding interface of HFE and TFR1.
• Utilizing in vitro proximity ligation assays to measure interference with HFE/TFR1 interaction.
• Stabilizing peptide helical conformation with sidechain lactam "staples" to evaluate impact on inhibitory activity.

Main Results:

• Peptides derived from the HFE/TFR1 interface significantly disrupted the interaction in vitro.
• Stabilizing the helical conformation of a peptide with lactam staples did not enhance its inhibitory effect.
• The study demonstrates the feasibility of targeting the HFE/TFR1 interaction with peptide inhibitors.

Conclusions:

• Peptide inhibitors targeting the HFE/TFR1 interaction were successfully developed.
• These peptides show potential as research tools for dissecting HFE's function in iron homeostasis.
• Further analysis using these inhibitors could elucidate HFE's role in regulating hepcidin expression.